Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001034280 | SCV001197618 | likely benign | not provided | 2025-01-18 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001034280 | SCV001477719 | uncertain significance | not provided | 2019-09-04 | criteria provided, single submitter | clinical testing | The CDHR1 c.1751C>T; p.Thr584Met variant (rs754321329), to our knowledge, is not reported in the medical literature or gene-specific databases. The variant is described in the general population with an allele frequency of 0.03% (92/282866 alleles including 1 homozygotes) in the Genome Aggregation Database. The amino acid at this position is highly conserved and computational algorithms (PolyPhen-2, SIFT) predict this variant is deleterious. Due to limited information, the clinical significance of this variant is uncertain. |
Ambry Genetics | RCV002552051 | SCV003687941 | uncertain significance | Inborn genetic diseases | 2021-10-12 | criteria provided, single submitter | clinical testing | The c.1751C>T (p.T584M) alteration is located in exon 15 (coding exon 15) of the CDHR1 gene. This alteration results from a C to T substitution at nucleotide position 1751, causing the threonine (T) at amino acid position 584 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |